Micro-cost Analysis of ALK Rearrangement Testing by FISH to...

  • Main
  • 2014 / 12
  • Micro-cost Analysis of ALK Rearrangement Testing by FISH to...
Clinical Medicine Insights Oncology 2014 / 12

Micro-cost Analysis of ALK Rearrangement Testing by FISH to Determine Eligibility for Crizotinib Therapy in NSCLC: Implications for Cost Effectiveness of Testing and Treatment

Parker, David, Belaud-Rotureau, M, Parker, David
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Medicine Insights: Oncology
DOI:
10.4137/cmo.s19236
Date:
December, 2014
File:
PDF, 1.17 MB
english, 2014
Conversion to is in progress
Conversion to is failed